Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1942 1
1943 4
1945 3
1947 1
1948 1
1951 1
1952 1
1953 4
1954 1
1955 3
1956 1
1957 2
1958 3
1960 4
1961 1
1963 1
1964 4
1965 4
1966 2
1967 3
1968 2
1969 2
1970 3
1971 5
1972 12
1973 14
1974 7
1975 8
1976 13
1977 5
1978 14
1979 16
1980 10
1981 11
1982 10
1983 14
1984 14
1985 11
1986 19
1987 15
1988 20
1989 12
1990 19
1991 16
1992 16
1993 24
1994 31
1995 37
1996 33
1997 34
1998 35
1999 30
2000 25
2001 26
2002 33
2003 33
2004 38
2005 20
2006 29
2007 25
2008 45
2009 42
2010 34
2011 28
2012 42
2013 50
2014 41
2015 55
2016 49
2017 39
2018 46
2019 41
2020 55
2021 51
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

1,318 results
Results by year
Filters applied: . Clear all
Page 1
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.
Gordon KB, Blauvelt A, Papp KA, Langley RG, Luger T, Ohtsuki M, Reich K, Amato D, Ball SG, Braun DK, Cameron GS, Erickson J, Konrad RJ, Muram TM, Nickoloff BJ, Osuntokun OO, Secrest RJ, Zhao F, Mallbris L, Leonardi CL; UNCOVER-1 Study Group; UNCOVER-2 Study Group; UNCOVER-3 Study Group. Gordon KB, et al. Among authors: erickson j. N Engl J Med. 2016 Jul 28;375(4):345-56. doi: 10.1056/NEJMoa1512711. Epub 2016 Jun 8. N Engl J Med. 2016. PMID: 27299809 Free article. Clinical Trial.
Cell quality control mechanisms maintain stemness and differentiation potential of P19 embryonic carcinoma cells.
Magalhães-Novais S, Bermejo-Millo JC, Loureiro R, Mesquita KA, Domingues MR, Maciel E, Melo T, Baldeiras I, Erickson JR, Holy J, Potes Y, Coto-Montes A, Oliveira PJ, Vega-Naredo I. Magalhães-Novais S, et al. Among authors: erickson jr. Autophagy. 2020 Feb;16(2):313-333. doi: 10.1080/15548627.2019.1607694. Epub 2019 Apr 24. Autophagy. 2020. PMID: 30990357 Free PMC article.
Ixekizumab treatment of biologic-naïve patients with active psoriatic arthritis: 3-year results from a phase III clinical trial (SPIRIT-P1).
Chandran V, van der Heijde D, Fleischmann RM, Lespessailles E, Helliwell PS, Kameda H, Burgos-Vargas R, Erickson JS, Rathmann SS, Sprabery AT, Birt JA, Shuler CL, Gallo G. Chandran V, et al. Among authors: erickson js. Rheumatology (Oxford). 2020 Oct 1;59(10):2774-2784. doi: 10.1093/rheumatology/kez684. Rheumatology (Oxford). 2020. PMID: 32031665 Free PMC article. Clinical Trial.
Instrumentation in Arthroscopy.
Barp EA, Erickson JG, Reese ER. Barp EA, et al. Among authors: erickson jg. Clin Podiatr Med Surg. 2016 Oct;33(4):481-92. doi: 10.1016/j.cpm.2016.06.002. Clin Podiatr Med Surg. 2016. PMID: 27599434 Review.
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K; UNCOVER-2 and UNCOVER-3 investigators. Griffiths CE, et al. Among authors: erickson j. Lancet. 2015 Aug 8;386(9993):541-51. doi: 10.1016/S0140-6736(15)60125-8. Epub 2015 Jun 10. Lancet. 2015. PMID: 26072109 Clinical Trial.
1,318 results